NM_004048.4(B2M):c.67+19C>T AND multiple conditions
- Germline classification:
- Likely benign (1 submission)
- Last evaluated:
- Dec 11, 2021
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV002486819.1
Allele description [Variation Report for NM_004048.4(B2M):c.67+19C>T]
NM_004048.4(B2M):c.67+19C>T
Condition(s)
- Name:
- Familial visceral amyloidosis, Ostertag type (AMYLD2)
- Synonyms:
- Ostertag type amyloidosis; German type amyloidosis; Amyloidosis familial renal; See all synonyms [MedGen]
- Identifiers:
- MONDO: MONDO:0007099; MedGen: C0268389; Orphanet: 85450; OMIM: 105200
- Name:
- Hypoproteinemia, hypercatabolic (IMD43)
- Synonyms:
- IMMUNODEFICIENCY 43; BETA-2-MICROGLOBULIN DEFICIENCY; B2M DEFICIENCY; See all synonyms [MedGen]
- Identifiers:
- MONDO: MONDO:0009434; MedGen: C1855796; OMIM: 241600
-
Discussion - Clinical Review Report: Ixekizumab (Taltz)
Discussion - Clinical Review Report: Ixekizumab (Taltz)
-
Acaryochloris thomasi RCC1774 RCC1774_contig008, whole genome shotgun sequence
Acaryochloris thomasi RCC1774 RCC1774_contig008, whole genome shotgun sequencegi|1402547465|gb|PQWO01000008.1||gn :PQWO01|RCC1774_contig008Nucleotide
-
Acaryochloris thomasi RCC1774 RCC1774_contig050, whole genome shotgun sequence
Acaryochloris thomasi RCC1774 RCC1774_contig050, whole genome shotgun sequencegi|1402544922|gb|PQWO01000050.1||gn :PQWO01|RCC1774_contig050Nucleotide
-
Trichomycterus candidus isolate LBPV-58011 voucher LBP11630 recombination activa...
Trichomycterus candidus isolate LBPV-58011 voucher LBP11630 recombination activating protein 2 (RAG2) gene, partial cdsgi|1233260173|gb|KY858189.1|Nucleotide
-
Emiliania huxleyi strain RCC1760 18S ribosomal RNA gene, partial sequence
Emiliania huxleyi strain RCC1760 18S ribosomal RNA gene, partial sequencegi|959096732|gb|KT861271.1|Nucleotide
Your browsing activity is empty.
Activity recording is turned off.
See more...Assertion and evidence details
Last Updated: Sep 29, 2024